Unlock stock picks and a broker-level newsfeed that powers Wall Street.
0.2123
+0.0023
+(1.10%)
At close: April 1 at 4:00:00 PM EDT
0.2098
-0.00
(-1.18%)
After hours: April 1 at 7:49:21 PM EDT
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (1970) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (1970) |
---|---|---|---|---|
No. of Analysts | -- | -- | 1 | -- |
Avg. Estimate | -- | -- | -- | -- |
Low Estimate | -- | -- | -- | -- |
High Estimate | -- | -- | -- | -- |
Year Ago Sales | -- | -- | -- | -- |
Sales Growth (year/est) | -- | -- | 0.00% | -- |
EPS Trend
Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (1970) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (1970) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
OGEN | -- | -- | -- | -- |
S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Related Tickers
AZTR Azitra, Inc.
0.2900
-4.29%
HCWB HCW Biologics Inc.
0.2809
-0.43%
ENTO Entero Therapeutics, Inc.
0.4101
-14.58%
INAB IN8bio, Inc.
0.1727
+4.04%
TCBPY TC Biopharm (Holdings) Plc
0.3200
+52.38%
QNRX Quoin Pharmaceuticals, Ltd.
0.2116
-7.68%
APTO Aptose Biosciences Inc.
1.7100
-45.97%
SXTP 60 Degrees Pharmaceuticals, Inc.
1.8900
+5.00%
SCPX Scorpius Holdings, Inc.
0.1282
-7.77%
RLMD Relmada Therapeutics, Inc.
0.2736
+1.33%